Inhibition of total flavonoids from <i>Abelmoschus Manihot</i> on cytochrome P450

XU Yao; PENG Ying; WANG Guangji; SUN Jianguo

doi:10.11665/j.issn.1000-5048.2023021402

Journal of China Pharmaceutical University > 2023 > 54(2): 208-217. > DOI: 10.11665/j.issn.1000-5048.2023021402

XU Yao, PENG Ying, WANG Guangji, SUN Jianguo. Inhibition of total flavonoids from Abelmoschus Manihot on cytochrome P450[J]. Journal of China Pharmaceutical University, 2023, 54(2): 208-217. DOI: 10.11665/j.issn.1000-5048.2023021402

Citation:

PDF (1619 KB)

Inhibition of total flavonoids from Abelmoschus Manihot on cytochrome P450

Key Laboratory of Drug Metabolism and Pharmacokinetics, China Pharmaceutical University, Nanjing 210009, China

Funds: This study was supported by the Innovation Fund for Medical Sciences of Chinese Academy of Medical Sciences (No.2021-I2M-5-011)

More Information

Received Date: February 13, 2023
Revised Date: April 07, 2023

Graphical Abstract

Abstract

Abstract

To investigate the influential mechanism of total flavonoids from Abelmoschus Manihot (HKZ) on cytochrome P450 (CYP450) isoforms in human liver microsomes and to verify its effect on the most significantly inhibited subtype CYP2C9 in rats.The inhibitory effects of HKZ on human CYP3A4, CYP2C9, CYP2C19, CYP2E1, CYP1A2 and CYP2D6 were evaluated through the cocktail method using ultra-performance liquid chromatography tandem mass spectrometry, then its inhibitory mechanism was investigated and kinetic parameters of enzyme inhibition were calculated By comparing the pharmacokinetic behaviors of tolbutamide after single or multiple administration of 200 mg/kg HKZ and equal dose of CMC-Na in rats, the effects of HKZ on CYP2C11 enzyme (CYP2C9 isoenzyme) was estimated.The results indicated the significant inhibitory effect of HKZ on CYP2C9 and CYP2E1 with IC₅₀ of 3.22 and 8.64 μg/mL, respectively. Also, it showed certain inhibitory ability on other isoforms with IC₅₀ of 20-30 μg/mL.As demonstrated, HKZ may not be a time-dependent inhibitor which competitively inhibited CYP2E1 and CYP2C9 with K_i of 3.84 and 6.33 μg/mL.In contrast, it showed noncompetitive inhibition on CYP3A4 mediated testosterone-6β-hydroxylation and midazolam-4-hydroxylation reaction with K_i of 7.37 and 3.32 μg/mL.It was also a noncompetitive inhibitor of CYP1A2, CYP2D6 and CYPC219 with K_i values of 8.66, 11.49 and 21.94 μg/mL. HKZ did not change the pharmacokinetic parameters of CYP2C11 probe substrate tolbutamide in rat, but it affected the AUC_0-t, c_max of 4-hydroxytolubutamide (P < 0.05). Therefore, drug-drug interaction mediated by CYP450 should be considered in clinical study.
- total flavonoids from Abelmoschus Manihot,
- CYP450 enzyme,
- inhibition kinetics,
- pharmacokinetics,
- tolbutamide

FullText(HTML)

References (34)

References

[1]	Yin SX, Cai ZC, Chen CH, et al. Comparative study on chemical constituents of medicinal and non-medicinal parts of Flos abelmoschus manihot, based on metabolite profiling coupled with multivariate statistical analysis[J]. Horticulturae, 2022, 8(4): 317.
[2]	Xia KY, Zhang CL, Cao ZY, et al. Chemical constituents from Corolla abelmoschi[J]. Strait Pharm J (海峡药学), 2019, 31(9): 58-61.
[3]	Yin SX, Wei lf, Mei YQ, et al. Simultaneous determination of multiple bioactive constituents in Abelmoschi Corolla by UFLC-QTRAP-MS/MS[J]. China J Chin Mater Med (中国中药杂志), 2021, 46(10): 2527-2536.
[4]	Li SH, Li N, Qin SS, et al. Purification, characterization and bioactivities of polysaccharides from the stalk of Abelmoschus manihot (L.) medic[J]. Food Sci Technol Res, 2020, 26(5): 611-621.
[5]	Luan F, Wu QH, Yang Y, et al. Traditional uses, chemical constituents, biological properties, clinical settings, and toxicities of Abelmoschus manihot L. : a comprehensive review[J]. Front Pharmacol, 2020, 11: 1068.
[6]	Han WB, Ma Q, Liu YL, et al. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling[J]. Phytomedicine, 2019, 57: 203-214.
[7]	Deng JF, He ZP, Li XR, et al. Huangkui capsule attenuates lipopolysaccharide-induced acute lung injury and macrophage activation by suppressing inflammation and oxidative stress in mice[J]. Evid Based Complement Alternat Med, 2021, 2021: 6626483.
[8]	Cai HD, Tao WW, Su SL, et al. Antidepressant activity of flavonoid ethanol extract of Abelmoschus manihot Corolla with BDNF up-regulation in the hippocampus[J]. Acta Pharm Sin (药学学报), 2017, 52(2): 222-228.
[9]	Gao YN, Liang ZH, Lv NY, et al. Exploring the total flavones of Abelmoschus manihot against IAV-induced lung inflammation by network pharmacology[J]. BMC Complement Med Ther, 2022, 22(1): 36.
[10]	Pan XX, Tao JH, Jiang S, et al. Characterization and immunomodulatory activity of polysaccharides from the stems and leaves of Abelmoschus manihot and a sulfated derivative[J]. Int J Biol Macromol, 2018, 107: 9-16.
[11]	Hou JH, Qian JJ, Li ZL, et al. Bioactive compounds from Abelmoschus manihot l. alleviate the progression of multiple myeloma in mouse model and improve bone marrow microenvironment[J]. Onco Targets Ther, 2020, 13: 959-973.
[12]	Yang BL, Zhu P, Li YR, et al. Total flavone of Abelmoschus manihot suppresses epithelial-mesenchymal transition via interfering transforming growth factor-β1 signaling in Crohn''s disease intestinal fibrosis[J]. World J Gastroenterol, 2018, 24(30): 3414-3425.
[13]	Yang ZZ, Tang HT, Shao Q, et al. Enrichment and purification of the bioactive flavonoids from flower of Abelmoschus manihot (L.) medic using macroporous resins[J]. Molecules, 2018, 23(10): 2649.
[14]	Lai XY, Liang H, Zhao YY, et al. Simultaneous determination of seven active flavonols in the flowers of Abelmoschus manihot by HPLC[J]. J Chromatogr Sci, 2009, 47(3): 206-210.
[15]	Dahlinger D, Duechting S, Nuecken D, et al. Development and validation of an in vitro, seven-in-one human cytochrome P450 assay for evaluation of both direct and time-dependent inhibition[J]. J Pharmacol Toxicol Methods, 2016, 77: 66-75.
[16]	Liu ZX, Liu SJ, Ju WZ, et al. Effects of Huangkui Capsule on the P450 activities in rats[J]. Chin J Clin Pharmacol Ther (中国临床药理学与治疗学), 2010, 15(4): 367-372.
[17]	Moon YJ, Wang XD, Morris ME. Dietary flavonoids: effects on xenobiotic and carcinogen metabolism[J]. Toxicol Vitro, 2006, 20(2): 187-210.
[18]	Ortiz-Andrade R, Araujo-León JA, Sánchez-Recillas A, et al. Toxicological screening of four bioactive citroflavonoids: in vitro, in vivo, and in silico approaches[J]. Molecules, 2020, 25(24): 5959.
[19]	Kahma H, Aurinsalo L, Neuvonen M, et al. An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes-application to establishing CYP2C8 inhibitor selectivity[J]. Eur J Pharm Sci, 2021, 162: 105810.
[20]	Jia YW, Peng Y, Sun JG, et al. "N-in-One Cocktail" method to evaluate inhibition effects of 4-hydroxylmethylphenyl-O-β-D-pyranosyl alloside on CYP450 enzymes[J]. Chin J Clin Pharmacol Ther (中国临床药理学与治疗学), 2014, 19(12): 1371-1375.
[21]	Lou D, Bao SS, Li YH, et al. Inhibitory mechanisms of myricetin on human and rat liver cytochrome P450 enzymes[J]. Eur J Drug Metab Pharmacokinet, 2019, 44(5): 611-618.
[22]	Rastogi H, Jana S. Evaluation of inhibitory effects of caffeic acid and quercetin on human liver cytochrome P450 activities[J]. Phytother Res, 2014, 28(12): 1873-1878.
[23]	Ye LH, Yan MZ, Kong LT, et al. In vitro inhibition of quercetin and its glycosides on P450 enzyme activities[J]. Chin Pharm J(中国药学杂志), 2014, 49(12): 1051-1055.
[24]	Fantoukh OI, Dale OR, Parveen A, et al. Safety assessment of phytochemicals derived from the globalized South African rooibos tea (Aspalathus linearis) through interaction with CYP, PXR, and P-gp[J]. J Agric Food Chem, 2019, 67(17): 4967-4975.
[25]	Cui MY, Li CH, Kong XY, et al. Influence of Flavonoids from Galium verum L. on the activities of cytochrome P450 isozymes and pharmacokinetic and pharmacodynamic of warfarin in rats[J]. Phcog Mag, 2019, 15(65): 645-651.
[26]	Zhang D, Wu GD, Hao HM, et al. Effect of total flavonoids of Hippophae rhamnoides L. on the activity and mRNA expression of CYP450 in rats[J]. Phcog Mag, 2022, 18(77): 82-88.
[27]	Bi YF, Zhu HB, Pi ZF, et al. Effects of flavonoides from the leaves of Acanthopanax on the activity of CYP450 isozymes in rat liver microsomes by a UPLC-MS/MS and cocktail probe substrates method[J]. Chem J Chin Univ (高等学校化学学报), 2013, 34(5): 1067-1071.
[28]	Mohutsky M, Hall SD. Irreversible enzyme inhibition kinetics and drug-drug interactions[J]. Methods Mol Biol, 2021, 2342: 51-88.
[29]	Gao J, Zhang YJ, Lei XQ, et al. Risk assessment of the inhibition of hydroxygenkwanin on human and rat cytochrome P450 by cocktail method[J]. Toxicol Vitro, 2022, 79: 105281.
[30]	Ramos CH, Rolim TS, de Souza TP, et al. Effect of food phenolic compounds on the activity of rat liver CYP2C subfamily enzymes evaluated by a newly validated method of high-performance liquid chromatography[J]. Rev Virtual Quim, 2019, 11(5): 1444-1456.
[31]	Lu J, Ding TG, Qin X, et al. In vitro and in vivo evaluation of cucurbitacin E on rat hepatic CYP2C11 expression and activity using LC-MS/MS[J]. Sci China Life Sci, 2017, 60(2): 215-224.
[32]	Guo YJ, Zheng SL. Effect of myricetin on cytochrome P450 isoforms CYP1A2, CYP2C9 and CYP3A4 in rats[J]. Pharmazie, 2014, 69(4): 306-310.
[33]	Liu ZX, Zhou L, Ju WZ, et al. Simultaneous determination of 5 major compositions in Huangkui capsules by HPLC[J]. China Pharm (中国药房), 2011, 22(12): 1129-1131.
[34]	Hou CS, Yang ZH, Sun XB. Simultaneous determination of tolbutamide and its metabolite 4-hydroxytolbutamide, chlorzoxazone in rat plasma by LC-MS-MS and application to pharmacokinetic study[J]. Chin J Exp Tradit Med Formulae (中国实验方剂学杂志), 2013, 19(12): 144-150.

[1]	HAO Kun, YU Dan, WANG Guangji. Pharmacokinetic translational research from bench to bedside[J]. Journal of China Pharmaceutical University, 2015, 46(1): 50-57. DOI: 10.11665/j.issn.1000-5048.20150105
[2]	XU Dan, LI Feng, ZHANG Ji, ZHANG Mian, MEI Dan, LIU Xiaodong. Pharmacokinetics roles of organic anion transporting polypeptides[J]. Journal of China Pharmaceutical University, 2013, 44(5): 482-486. DOI: 10.11665/j.issn.1000-5048.20130519
[3]	WANG Meng, QIAO Hongqun, YAN Zhengyu. Pharmacokinetics of docetaxel SBE-β-cyclodextrin inclusion complex in rats[J]. Journal of China Pharmaceutical University, 2013, 44(2): 156-160. DOI: 10.11665/j.issn.1000-5048.20130211
[4]	SONG Xiao-chen, CHEN Lin-lin, QI Jin, YU Bo-yang, ZHU Dan-ni. Pharmacokinetics of hapagoside and its metabolite in rats[J]. Journal of China Pharmaceutical University, 2011, 42(3): 262-265.
[5]	Determination of Glibenclamide in Human Plasma by LC-MS and Study of Its Pharmacokinetics in Healthy Chinese Volunteers[J]. Journal of China Pharmaceutical University, 2004, (6): 51-54.
[6]	Pharmacokinetics of 0325k1-1 in Dogs[J]. Journal of China Pharmaceutical University, 2003, (4): 79-81.
[7]	Pharmacokinetics of Bacampicillin Tablets in Healthy Subjects[J]. Journal of China Pharmaceutical University, 2001, (4): 22-25.
[8]	Pharmacokinetics of Aceclofenac in Rats[J]. Journal of China Pharmaceutical University, 1998, (4): 68-70.
[9]	Pharmacokinetics and Pharmacodynamics of Sophocarpine and Oxysophocarpine[J]. Journal of China Pharmaceutical University, 1992, (3): 161-164.
[10]	PHARMACOKINETICS OF MATRINR IN RABBITS[J]. Journal of China Pharmaceutical University, 1986, (4): 309-311.

Cited By

Cited by

Periodical cited type(2)

1.	赵世宇，刘帅兵，姚霞，田鑫. 英菲格拉替尼及其活性代谢产物对大鼠肝微粒体中CYPs和UGTs的抑制作用. 中国临床药理学杂志. 2024(16): 2368-2372 .
2.	母磊鑫，刘湉，柯彩依，白延婷，马群，陈昭. 生物样品中5种CYP450酶底物分析方法的建立. 中国医药导报. 2024(25): 41-45 .

Other cited types(0)

Get Citation

PDF

XML

Article views (157) PDF downloads (373) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Inhibition of total flavonoids from Abelmoschus Manihot on cytochrome P450

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Inhibition of total flavonoids from Abelmoschus Manihot on cytochrome P450

Abstract

References

Related Articles

Cited by

Periodical cited type(2)

Other cited types(0)

Catalog

Export File

Citation

Format

Content